Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.

Blood - 1 Dec 2001

O'Connor F F, Shields D C, Fitzgerald A, Cannon C P, Braunwald E, Fitzgerald D J

Abstract excerpt

This study examined the influence of the Pl(A) polymorphism of glycoprotein IIIa (GPIIIa) in determining the response to an oral GPIIb/IIIa antagonist, orbofiban, in patients with unstable coronary syndromes. Genotyping for the Pl(A) polymorphism was performed in 1014 patients recruited into the OPUS-TIMI-16 (orbofiban in patients with unstable coronary syndromes-thrombolysis in myocardial infarction 16) trial,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angina, Unstable
Share to Antigens, Human Platelet

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aspirin

Share to Hemorrhage

Share to Myocardial Ischemia

Share to Placebos

Share to Platelet Glycoprotein GPIIb-IIIa Complex

Share to Pyrrolidines

Source

Identifiers

PMID: 11719362
DOI: 10.1182/blood.v98.12.3256

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes.PMID 11719362Read ↗

The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists.Semantic proximity Read ↗

Platelet glycoprotein Ib alpha receptor polymorphisms and recurrent ischaemic events in acute coronary syndrome patients.Semantic proximity Read ↗

Role of platelet glycoprotein polymorphisms in cardiovascular diseases.Semantic proximity Read ↗

The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.Semantic proximity Read ↗

Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?Semantic proximity Read ↗

Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.Semantic proximity Read ↗

Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.Semantic proximity Read ↗

The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.Semantic proximity Read ↗

Glycoprotein IIIa polymorphism and risk of myocardial infarction.Semantic proximity Read ↗

Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events.Semantic proximity Read ↗

Effects of genetic variation in protease activated receptor 4 after an acute coronary syndrome: Analysis from the TRACER trial.Semantic proximity Read ↗

The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.